65
Han X#, Chen L, Wang Y, Li H, Wang H, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu X*, Cao B*, CAP-China Network. Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infect Drug Resist. 2021 May 18;14:1845-1853. doi: 10.2147/IDR.S302852. eCollection 2021.
66
Huang L#,Cao B*. Post-acute conditions of patients with COVID-19 not requiring hospital admission. Lancet Infect Dis. 2021 May 10;S1473-3099(21)00225-5. doi: 10.1016/S1473-3099(21)00225-5. Online ahead of print.
67
Shang L#, David Chien Lye,Cao B*. Contemporary narrative review of treatment options for COVID-19. Respirology. 2021 Aug;26(8):745-767. doi: 10.1111/resp.14106. Epub 2021 Jul 8.
68
Gu X, Cao B. In-hospital complications associated with COVID-19. Lancet. 2021 Jul 17;398(10296):188-190. doi: 10.1016/S0140-6736(21)00983-1.
69
Xu J#, Cao B*. Letter from China: Managing the second-wave COVID-19 outbreak in Beijing. Respirology. 2021 Jan 5. doi: 10.1111/resp.14002. Online ahead of print.
70
Liu S#, Huang Z#, Deng X, Zou X, Li H, Mu S, Cao B*. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021 Jan 14. doi: 10.1111/jcmm.16275. Online ahead of print.
71
Li H#, Gu X#, Li H#, Gong F#, Xu J, Wang Y, Li H, Ruan S, Yang Q, Cao B*. Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe COVID-19. Chest. 2021 Jan 6;S0012-3692(21)00007-6. doi: 10.1016/j.chest.2020.11.071.
73
李丽娟﹟,黎斌斌,王一民,王春雷,孙凌霄,刘颖梅,鲁炳怀,曹彬*.成人副流感病毒下呼吸道感染患者临床特征和预后分析[J].中华医学杂志,2020,100(27):2109-2115.
75
李丽娟﹟,刘思危,孙凌霄,王一民,刘颖梅,王金祥,任亚莉,刘波,潘建亮,刘菲菲,宋丽斯,王传,曹彬*.成人鼻病毒肺炎临床特征和混合感染病原学特点分析[J].中国呼吸与危重监护杂志,2020,19(05):451-456.
77
Carlos WG, Cruz CSD, Cao B, Gross JE, Pasnick S, Jamil S. COVID-19: How Do We Stay Safe? Am J Respir Crit Care Med. 2020 Sep 1;202(5):P15-P16. doi: 10.1164/rccm.2025P15.
78
Han X﹟*, Liu X, Chen L, Wang Y, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Cao B; CAP-China network. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020 Sep 12;20(1):668. doi: 10.1186/s12879-020-05362-3.
79
Shang L﹟, Gu X﹟, Du S, Wang Y, Cao B*, Wang C*; CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: a systematic review. Clin Respir J. 2020 Sep 17. doi: 10.1111/crj.13273. Epub ahead of print.
80
Wang Y﹟, Gu X, Xu J, Cao B*, Wang C. Remdesivir and COVID-19 - Authors' reply. Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8.
